Charles River Laboratories International, Inc. has announced the promotion of Foster Jordan to Corporate Senior Vice President, Endotoxin & Microbial Detection Products. “With Foster’s direction our in vitro solutions are market leaders and pillars in the Company’s success. His ability to anticipate both industry and customer demands will help drive the continued growth and profitability of our in vitro business moving forward,” said James C. Foster, Chairman, President, and Chief Executive Officer of Charles River. Mr. Jordan joined Charles River in 1994 following the acquisition of Endosafe. He became Executive Director, In Vitro Detection Systems in 2001 and a Corporate Vice President in 2006. Mr. Jordan was instrumental in the development of the Company’s FDA-licensed in vitro endotoxin detection test kits. Under his leadership, Charles River’s in vitro business continues to evolve and meet the increased market demand for rapid, real-time endotoxin testing. The innovative solutions support the FDA’s Process Analytical Technology (PAT) initiative. “The increased customer demand, coupled with the PAT initiative, makes this a very exciting time for in vitro endotoxin detection tests,” said Foster Jordan, Corporate Senior Vice President, Endotoxin & Microbial Detection Products. “More and more customers are realizing rapid FDA approved endotoxin detection is the future and I look forward to helping these organizations implement best practices with Charles River solutions.”